HELP 6-K: SEC filing

Helus Pharma Inc.

Filed with the SEC on · accession 0001833141-26-000100

HELP filed a 6-K (foreign company report) with the SEC on Nov 13, 2026. How foreign companies listed in the US report news and events — like an 8-K for them. The stock moved +0.1% by the first close after the filing.

Summary of the filing

Helus Pharma Inc. filed a Form 6-K furnishing its interim consolidated financial statements and MD&A for the three and six months ended September 30, 2026, along with CEO and CFO certifications.

Key details

RegistrantHelus Pharma Inc.
Chief financial officerGreg Cavers

How HELP stock reacted

Close before

$8.86

Nov 12, 2026

First close after

+0.11%

$8.87

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for HELP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for HELP?

Click here

Frequently asked questions

What did HELP file with the SEC on Nov 13, 2026?

HELP filed a 6-K (SEC filing). Helus Pharma Inc. filed a Form 6-K furnishing its interim consolidated financial statements and MD&A for the three and six months ended September 30, 2026, along with CEO and CFO certifications.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

How did HELP stock react to this filing?

HELP closed at $8.86 before the filing and $8.87 on Nov 13, 2026 (+0.11%).

Other HELP SEC filings

Get alerts when HELP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days